Although serious hypoglycemia is a common adverse drug event in ambulatory care, current performance measures do not assess potential overtreatment.
To identify high-risk patients who had evidence of intensive glycemic management and thus were at risk for serious hypoglycemia.
Design, Setting, and Participants
JAMA Intern Med.
JAMA Intern Med. Published online December 09, 2013. doi:10.1001/jamainternmed.2013.12963